Search clinical trials for: MT101-5

Total 7775 results

Mthera Pharma Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects With Early Parkinson's Disease

Parkinson's Disease
Mthera Pharma Co., Ltd.
Amarex Clinical Research

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Profile of MT101-5 in Healthy Volunteers

Parkinson's Disease

United States
Bionovo

Unknown

A Study of MF101 in Postmenopausal Women (HERBA)

Vasomotor Symptoms | Hot Flushes

United States
Qingdao Sino-Cell Biomedicine Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; West China... and other collaborators

Recruiting

HS-IT101 Injection in the Treatment of Advanced Solid Tumors

Solid Tumor

China
Grit Biotechnology

Recruiting

GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors

Solid Tumors, Adult

China
Bionovo

Completed

Sleep Quality in CHIMES (MF101)

Sleep Quality | Menopausal Symptoms

United States
Shaanxi Micot Technology Limited Company
WCCT Global

Completed

MT1013 Clinical TRIAL In Healthy Subject

Healthy Volunteer

United States
Bionovo

Completed

Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes

Hot Flashes

United States
Grit Biotechnology

Recruiting

GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors

Adult

China
Bionovo

Terminated

Phase I Study to Evaluate the Safety and Efficacy of MF101 as Well as the Pharmacokinetics of Its Key Active Components

Healthy

United States
Bionovo

Unknown

A Clinical Trial Assessing Safety of MF101 for Hot Flushes

Hot Flashes

United States
Hugel

Completed

Study to Investigate the Pharmacokinetics, Safety, and Tolerability of BMT101 in Healthy Male Volunteers

Hypertrophic Scar

Korea, Republic of
Sonexa Therapeutics, Inc.

Completed

Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease

Alzheimer's Disease

United States, Canada
Sonexa Therapeutics, Inc.

Completed

A Pilot Efficacy and Safety Study of ST101 in Essential Tremor

Essential Tremor

United States
Universidad Complutense de Madrid

Recruiting

Ligilactobacillus Salivarius MP101 for Elderly in a Nursing Home (PROBELDERLY)

Covid19

Spain
Hugel

Terminated

the Hypertrophic Scar Prevention of BMT101.

Hypertrophic Scar

Korea, Republic of
Amgen
MedImmune LLC

Terminated

A Phase 1 Study of AMG 211 in Participants With Advanced Gastrointestinal Cancer

GI Adenocarcinoma

Germany, Netherlands
Mezzion Pharma Co. Ltd
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

Evaluation of Fontan-Associated Liver Disease (FALD)

Single Ventricle Heart Disease

United States, Canada
Tera Group

Not yet recruiting

Breath Samples Collection Clinical Trial, for Development of the TERA BioStation T101, Intended for CoV-19 Exhalation Products Detection.

COVID-19
Merck Sharp & Dohme LLC

Completed

A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)

Ulcerative Colitis

United States, Georgia, Germany, Hungary, Moldova, Republic of, Poland, Ukraine, United Kingdom
Amgen Research (Munich) GmbH

Completed

Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia

Germany
Sonexa Therapeutics, Inc.

Completed

Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease

Alzheimer's Disease

United States, Canada
Amgen Research (Munich) GmbH

Completed

Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL

Non-Hodgkin's Lymphoma, Relapsed

Germany
The Affiliated Hospital of Qingdao University
Qingdao Sino-Cell Biomedicine Co.,Ltd.

Not yet recruiting

Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor

Advanced Solid Tumor
The Affiliated Hospital of Qingdao University
Qingdao Sino-Cell Biomedicine Co.,Ltd.

Not yet recruiting

Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer

Breast Cancer

China
Amgen Research (Munich) GmbH

Completed

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer (MT110-101)

Solid Tumors

Germany
Seoul National University Hospital

Completed

Development of Fecal Scoring for the Management of Fecal Impaction With Regards to Lower Urinary Tract Dysfunction

Bowel Dysfunction | Bladder Dysfunction | Fecal Impaction | Lower Urinary Tract Disorder

Korea, Republic of
Amgen Research (Munich) GmbH

Completed

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

United States, Germany, Austria, Canada, France, Italy, Netherlands
Amgen Research (Munich) GmbH

Completed

Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)

B-ALL

Germany
Amgen Research (Munich) GmbH

Completed

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Diffuse Large B-cell Lymphoma

Germany
Amgen Research (Munich) GmbH

Completed

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia

United States, United Kingdom, Germany, Spain, France, Italy
Tasly Tianjin Biopharmaceutical Co., Ltd.

Completed

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients

Hepatitis B Virus (HBV)

China
Amgen Research (Munich) GmbH

Completed

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) (BLAST)

B-cell Acute Lymphoblastic Leukemia

Austria, Belgium, France, Germany, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
Institut für Pneumologie Hagen Ambrock eV
Fisher and Paykel Healthcare

Completed

Efficacy and Physiology of Nasal High Flow Therapy

Pulmonary Disease, Chronic Obstructive

Germany
National Institute of Public Health, Cambodia
Emory University; World Vision International; World Vision, Hong Kong; World Vision...

Completed

Innovative Nutrition and mHealth Evidence Building Project

Underweight Children Aged 6-23 Month Old (WAZ < -1)

Cambodia
Tasly Tianjin Biopharmaceutical Co., Ltd.

Unknown

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients

Hepatitis B Virus (HBV)

China
ClinAmygate
Aswan University Hospital

Recruiting

A (5-5-5-8) Technique for Laparoscopic Cholecystectomy

Cholecystolithiasis | Cholecystitis; Gallstone | Cholecystitis, Chronic

Egypt
Peking University

Recruiting

JMT101 Combined With Afatinib in Patients With Advanced Esophageal Squamous Cell Carcinoma After Standard Therapy

Esophageal Squamous Carcinoma

China
AbClon

Recruiting

Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

B-cell Non Hodgkin Lymphoma

Korea, Republic of
Grit Biotechnology

Not yet recruiting

Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer

Adult

China
Sapience Therapeutics

Recruiting

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Breast Cancer | Glioblastoma | Prostate Cancer | Brain Cancer | Glioblastoma Multiforme | GBM | Metastatic Breast Cancer | Recurrent Glioblastoma | Metastatic Melanoma | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Newly Diagnosed Glioblastoma | Melanoma Stage IV | Melanoma Recurrent

United States, United Kingdom
Amgen

Completed

Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia

China
Taipei Medical University Shuang Ho Hospital

Completed

Effect of Ureteral Stents Length and Location on Related Symptom

Lower Urinary Tract Symptoms | Overactive Bladder Syndrome

Taiwan
U.S. Army Medical Research and Development Command

Recruiting

An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample

Stress Disorders, Post-Traumatic

United States
Shanghai JMT-Bio Inc.

Not yet recruiting

Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer

Squamous Cell Non-small Cell Lung Cancer
Shanghai JMT-Bio Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer

Locally Advanced or Metastatic Non-Small Cell Lung Cancer | EGFR Exon20 Insertion Mutations
Suzhou Kintor Pharmaceutical Inc,
Suzhou Koshine Biomedica, Inc.

Active, not recruiting

Phase III Study of KX-826 With Adult Male Patients With AGA

Androgenetic Alopecia

China
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

Benign Prostatic Hyperplasia
University of Hawaii
SBI ALApromo Co., Ltd. - Strategic Business Innovator

Completed

Use Of The Dietary Supplement 5-ALA And Its Relationship With Sleep And Mood

Stress | Insomnia | Irritability | Coping Behavior | Nocturnal Awakening

United States
Shanghai JMT-Bio Inc.

Not yet recruiting

A Study of JMT101 in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer (mCRC)

Search clinical trials for: MT101-5

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations